Showing results (141-150 of 296) with videos related to

Sort By:
Pageof 30
International Journal of Nanomedicine|November 3, 2010
Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubesAlessandro Ruggiero, Carlos H Villa, Jason P Holland, et al.
Oncoimmunology|June 9, 2021
Low-dose CDK4/6 inhibitors induce presentation of pathway specific MHC ligands as potential targets for cancer immunotherapyAngel Charles, Christopher M Bourne, Tanya Korontsvit, et al.
Bioconjugate Chemistry|December 28, 2016
Near-Infrared Quantum Dot and <sup>89</sup>Zr Dual-Labeled Nanoparticles for in Vivo Cerenkov ImagingYiming Zhao, Travis M Shaffer, Sudeep Das, et al.
Blood|June 26, 2004
Targeted deletion of T-cell clones using alpha-emitting suicide MHC tetramersRui Rong Yuan, Phillip Wong, Michael R McDevitt, et al.
Assay and Drug Development Technologies|December 24, 2011
A high-throughput scintillation proximity-based assay for human DNA ligase IVHui-Min Tseng, David Shum, Bhavneet Bhinder, et al.
Oncoimmunology|March 5, 2016
T cell receptor mimic antibodies for cancer therapyLeonid Dubrovsky, Tao Dao, Ron S Gejman, et al.
American Journal of Nuclear Medicine and Molecular Imaging|November 8, 2012
Cerenkov imaging - a new modality for molecular imagingDaniel Lj Thorek, Robbie Robertson, Wassifa A Bacchus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
CD8+ T-cell-dependent immunity following xenogeneic DNA immunization against CD20 in a tumor challenge model of B-cell lymphomaMaria Lia Palomba, Wendy K Roberts, Tao Dao, et al.
ACS Nano|March 27, 2023
Translatable Drug-Loaded Iron Oxide Nanophore Sensitizes Murine Melanoma Tumors to Monoclonal Antibody ImmunotherapyEvan P Stater, George Morcos, Elizabeth Isaac, et al.
JCI Insight|September 8, 2020
Solving an MHC allele-specific bias in the reported immunopeptidomeMartin G Klatt, Kyeara N Mack, Yang Bai, et al.
Pageof 30